Chiroscience Group Plc was a British-based biotech company, founded by Christopher Evans. The company was taken over by Celltech in 1999, which was acquired in 2004 by UCB.
History
Chiroscience was born from the demise of the company Enzymatix, which was ultimately acquired by Genzyme,[2] when Andrew Richards joined the company and convinced Evans and Peter Keen to launch Chiros, name of which was quickly revised to Chrioscience.[3] Seed funding for the company of GB£3 million was provided by Schroder Ventures, Apax and 3i.[3] Chiroscience became one of the first biotechnology